Shifting paradigms in the treatment of chronic lymphocytic leukemia.

about

Management of Chronic Lymphocytic Leukemia in the Elderly Targeting ATM-deficient CLL through interference with DNA repair pathways

P2860

Q26775983-ECFBDE7B-3A75-45A5-92E0-ECA6AD7FF92F Q26822592-B49C4304-B397-4D24-ACEB-B93C29AF89D3

P2860

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q38357127

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

@en

type

Item

label

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

@en

prefLabel

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

@en

P1476

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

@en

P2093

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Philip A Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.

TP53 mutation and survival in chronic lymphocytic leukemia.

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Nivolumab plus ipilimumab in advanced melanoma.

P304

641-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.14.288

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Keating

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25686119

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

about

P2860

P2860

Shifting paradigms in the treatment of chronic lymphocytic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921